Nodal radiotherapy for prostate adenocarcinoma recurrence: predictive factors for efficacy.

Date publication

octobre 2024

Journal

Frontiers in oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr QUIVRIN Magali

Tous les auteurs :
Gueiderikh A, Baude J, Baron D, Schiappa R, Katsahian S, Moreau D, Laurans M, Bibault JE, Kreps S, Bondiau PY, Quivrin M, Lépinoy A, Pasquier D, Hannoun-Levi JM, Giraud P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39525616

Résumé

Nodes are the second site for prostate cancer recurrence. Whole-pelvic radiotherapy (WPRT) has shown superiority over nodal stereotactic body radiotherapy (SBRT) in two retrospective cohorts. We aimed to compare both modalities and assess factors associated with treatment outcomes.

Mots clés

PSA doubling time, SBRT (stereotactic body radiation therapy), androgen deprivation therapy (ADT), nodal recurrence, prostate adenocarcinoma, whole pelvic radiation therapy

Référence

Front Oncol. 2024 10 25;14:1468248